Hans Moebius
2021
In 2021, Hans Moebius earned a total compensation of $2.2M as Chief Medical Officer at Athira Pharma.
Compensation breakdown
| Non-Equity Incentive Plan | $206,400 |
|---|---|
| Option Awards | $1,124,899 |
| Salary | $362,125 |
| Stock Awards | $460,200 |
| Other | $74,697 |
| Total | $2,228,321 |
Moebius received $1.1M in option awards, accounting for 50% of the total pay in 2021.
Moebius also received $206.4K in non-equity incentive plan, $362.1K in salary, $460.2K in stock awards and $74.7K in other compensation.
Rankings
In 2021, Hans Moebius' compensation ranked 5,615th out of 12,415 executives tracked by ExecPay. In other words, Moebius earned more than 54.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,615 out of 12,415 | 55th |
Division Manufacturing | 2,379 out of 5,505 | 57th |
Major group Chemicals And Allied Products | 1,033 out of 2,375 | 57th |
Industry group Drugs | 922 out of 2,096 | 56th |
Industry Biological Products, Except Diagnostic Substances | 224 out of 449 | 50th |
Source: SEC filing on April 5, 2023.
Moebius' colleagues
We found two more compensation records of executives who worked with Hans Moebius at Athira Pharma in 2021.